⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Corentec Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Corentec Co., Ltd.
↗Cheonan, South Korea
Corentec is a global medical device company specializing in the development, manufacturing, and marketing of orthopedic implants. Its primary product portfolio includes artificial hip and knee joint systems, spinal fixation devices, and shoulder joints, designed to provide high-quality, affordable alternatives to premium market offerings.
Headquartered in South Korea, the company has expanded its reach internationally, including the establishment of Corentec America, Inc. to serve the U.S. market. In recent years, Corentec has diversified its business by acquiring Woosung Pharmaceutical, aiming to integrate pharmaceutical solutions with its orthopedic implant business to become a comprehensive healthcare provider.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$75M-$100M
Founded:2000
Ownership:public
Status:operating
STOCK
Exchange:KOSDAQ
Ticker:104540
Market Cap:$0.05B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Medical Devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Corentec America Inc., Woosung Pharmaceutical
Key Partnerships:Hospital networks in South Korea and international distribution partners
COMPETITION
Position:Niche Player
Competitors:Stryker, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), Smith+Nephew, Medacta International
LEADERSHIP
Key Executives:
Seok-Hee Kang - CEO
LINKS
Website:corentec.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Corentec Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.